Cancer Research Campaign operation manual for control recommendations for products derived from recombinant DNA technology prepared for investigational administration to patients with cancer in phase I trials

Eur J Cancer. 1993;29A(13):1907-10. doi: 10.1016/0959-8049(93)90549-u.
No abstract available

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials, Phase I as Topic*
  • Consumer Product Safety
  • DNA, Recombinant
  • Drug Labeling
  • Humans
  • Recombinant Proteins / isolation & purification
  • Recombinant Proteins / therapeutic use*
  • Recombination, Genetic

Substances

  • Antineoplastic Agents
  • DNA, Recombinant
  • Recombinant Proteins